View of Regulatory approach and analysis of clinical pharmacology studies by the National Administration of Medicines, Food and Medical Devices during the COVID-19 pandemic

Return to Article Details Regulatory approach and analysis of clinical pharmacology studies by the National Administration of Medicines, Food and Medical Devices during the COVID-19 pandemic Download Download PDF